ISSN: 2522-9176
Comparison of three HDV-RNA quantitative commercially available tests in untreated and in myrcludex-B treated patients with hdv related chronic hepatitis in a real-life setting
Page Header Logo EURASIAN JOURNAL OF CLINICAL SCIENCES

Abstract

As new anti-hepatitis delta (HDV) therapies are being developed, highly sensitive and reliable quantitative tests are needed. Aim of the study was to compare three commercially available HDV-RNA kits. Methods. 92 serum samples from 4 categories of patients were tested for HDV-RNA by 3 assays: RoboGene (HDV-RNA quantification 2.0, Aj-Roboscreen, Germany, LLQ 6 IU/mL), EurobioPlex (HDV qRT-PCR, Eurobio, France, 100 IU/mL) and Dia.Pro (HDV-RNA Quantitation, Dia.Pro Diagnostic Bioprobes, Italy, 50 IU/mL). Total RNA was extracted by EZ1 DSP Virus Kit (Qiagen, Hilden, Germany).

References

APASL Single Topic Conference Delta Hepatitis

June 27-28, 2019 Baku, Azerbaijan

APASL STC 2019 DELTA HEPATITIS
PDF
PDF

Keywords

HDV-RNA
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

©2017 Eurasian Journal of Clinical Sciences. Uptodate In Medicine LLC Health Sciences Publishing. All rights reserved. Unauthorized use prohibited.